Soiken Holdings Inc. (2385.T)
JPY 129.0
(-1.53%)
JPY 129.0
(-1.53%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.94 Billion JPY | -15.7% |
| 2022 | 8.23 Billion JPY | -2.94% |
| 2021 | 8.48 Billion JPY | 18.79% |
| 2020 | 7.14 Billion JPY | -3.52% |
| 2019 | 7.4 Billion JPY | 17.91% |
| 2018 | 6.28 Billion JPY | 11.23% |
| 2017 | 5.64 Billion JPY | 1.91% |
| 2016 | 5.54 Billion JPY | 12.22% |
| 2015 | 4.93 Billion JPY | 12.46% |
| 2014 | 4.39 Billion JPY | 1.61% |
| 2013 | 4.32 Billion JPY | 1.07% |
| 2012 | 4.27 Billion JPY | 3.93% |
| 2011 | 4.11 Billion JPY | -4.02% |
| 2010 | 4.28 Billion JPY | -5.8% |
| 2009 | 4.55 Billion JPY | -22.18% |
| 2008 | 5.84 Billion JPY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 7.12 Billion JPY | -3.9% |
| 2023 FY | 6.94 Billion JPY | -15.7% |
| 2023 Q3 | 6.97 Billion JPY | -2.08% |
| 2023 Q1 | 7.41 Billion JPY | -10.01% |
| 2023 Q4 | 6.94 Billion JPY | -0.45% |
| 2022 Q1 | 7.88 Billion JPY | -7.06% |
| 2022 FY | 8.23 Billion JPY | -2.94% |
| 2022 Q4 | 8.23 Billion JPY | -5.07% |
| 2022 Q3 | 8.67 Billion JPY | 8.92% |
| 2022 Q2 | 7.96 Billion JPY | 1.0% |
| 2021 Q2 | 8.07 Billion JPY | 10.87% |
| 2021 FY | 8.48 Billion JPY | 18.79% |
| 2021 Q1 | 7.28 Billion JPY | 1.96% |
| 2021 Q4 | 8.48 Billion JPY | 5.37% |
| 2021 Q3 | 8.05 Billion JPY | -0.27% |
| 2020 Q2 | 7.24 Billion JPY | 2.88% |
| 2020 Q3 | 7.3 Billion JPY | 0.94% |
| 2020 FY | 7.14 Billion JPY | -3.52% |
| 2020 Q1 | 7.03 Billion JPY | -4.97% |
| 2020 Q4 | 7.14 Billion JPY | -2.23% |
| 2019 Q4 | 7.4 Billion JPY | 8.76% |
| 2019 FY | 7.4 Billion JPY | 17.91% |
| 2019 Q1 | 6.06 Billion JPY | -3.43% |
| 2019 Q2 | 6.47 Billion JPY | 6.73% |
| 2019 Q3 | 6.81 Billion JPY | 5.19% |
| 2018 FY | 6.28 Billion JPY | 11.23% |
| 2018 Q2 | 5.82 Billion JPY | 1.68% |
| 2018 Q1 | 5.72 Billion JPY | 1.43% |
| 2018 Q4 | 6.28 Billion JPY | 4.92% |
| 2018 Q3 | 5.98 Billion JPY | 2.79% |
| 2017 FY | 5.64 Billion JPY | 1.91% |
| 2017 Q4 | 5.64 Billion JPY | 4.64% |
| 2017 Q3 | 5.39 Billion JPY | 3.04% |
| 2017 Q2 | 5.23 Billion JPY | -0.01% |
| 2017 Q1 | 5.23 Billion JPY | -5.48% |
| 2016 Q3 | 4.87 Billion JPY | 1.1% |
| 2016 FY | 5.54 Billion JPY | 12.22% |
| 2016 Q1 | 4.7 Billion JPY | -4.78% |
| 2016 Q2 | 4.81 Billion JPY | 2.49% |
| 2016 Q4 | 5.54 Billion JPY | 13.74% |
| 2015 FY | 4.93 Billion JPY | 12.46% |
| 2015 Q4 | 4.93 Billion JPY | 5.41% |
| 2015 Q3 | 4.68 Billion JPY | 2.81% |
| 2015 Q2 | 4.55 Billion JPY | 3.51% |
| 2015 Q1 | 4.4 Billion JPY | 0.25% |
| 2014 FY | 4.39 Billion JPY | 1.61% |
| 2014 Q3 | 4.3 Billion JPY | 2.26% |
| 2014 Q4 | 4.39 Billion JPY | 1.93% |
| 2014 Q2 | 4.21 Billion JPY | 1.4% |
| 2014 Q1 | 4.15 Billion JPY | -3.87% |
| 2013 Q1 | 4.16 Billion JPY | -2.49% |
| 2013 Q4 | 4.32 Billion JPY | 0.33% |
| 2013 Q3 | 4.3 Billion JPY | 1.94% |
| 2013 Q2 | 4.22 Billion JPY | 1.34% |
| 2013 FY | 4.32 Billion JPY | 1.07% |
| 2012 Q1 | 4.16 Billion JPY | 1.2% |
| 2012 Q3 | 4.27 Billion JPY | 1.08% |
| 2012 Q4 | 4.27 Billion JPY | 0.08% |
| 2012 Q2 | 4.22 Billion JPY | 1.51% |
| 2012 FY | 4.27 Billion JPY | 3.93% |
| 2011 FY | 4.11 Billion JPY | -4.02% |
| 2011 Q2 | 4.13 Billion JPY | -1.73% |
| 2011 Q1 | 4.2 Billion JPY | -1.89% |
| 2011 Q3 | 4.11 Billion JPY | -0.44% |
| 2011 Q4 | 4.11 Billion JPY | -0.0% |
| 2010 Q3 | 4.35 Billion JPY | 0.21% |
| 2010 FY | 4.28 Billion JPY | -5.8% |
| 2010 Q2 | 4.34 Billion JPY | -2.5% |
| 2010 Q4 | 4.28 Billion JPY | -1.55% |
| 2010 Q1 | 4.45 Billion JPY | -2.08% |
| 2009 Q2 | 5.41 Billion JPY | -3.05% |
| 2009 Q4 | 4.55 Billion JPY | -12.25% |
| 2009 Q3 | 5.18 Billion JPY | -4.25% |
| 2009 Q1 | 5.58 Billion JPY | -4.47% |
| 2009 FY | 4.55 Billion JPY | -22.18% |
| 2008 Q2 | 6.05 Billion JPY | 0.0% |
| 2008 FY | 5.84 Billion JPY | 0.0% |
| 2008 Q4 | 5.84 Billion JPY | -1.55% |
| 2008 Q3 | 5.94 Billion JPY | -1.92% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 6.58 Billion JPY | -5.415% |
| PRISM BioLab Co.,LTD | 1.21 Billion JPY | -473.385% |
| GNI Group Ltd. | 62.39 Billion JPY | 88.867% |
| Linical Co., Ltd. | 18.53 Billion JPY | 62.534% |
| Trans Genic Inc. | 9.81 Billion JPY | 29.201% |
| MEDINET Co., Ltd. | 5.63 Billion JPY | -23.286% |
| Cytori Cell Research Institute, Inc. | 5.81 Billion JPY | -19.425% |
| AnGes, Inc. | 28.89 Billion JPY | 75.959% |
| OncoTherapy Science, Inc. | 867.27 Million JPY | -700.915% |
| Nxera Pharma Co., Ltd. | 157.19 Billion JPY | 95.581% |
| Immuno-Biological Laboratories Co., Ltd. | 1.61 Billion JPY | -329.149% |
| NanoCarrier Co., Ltd. | 5.07 Billion JPY | -36.97% |
| Carna Biosciences, Inc. | 4.34 Billion JPY | -59.685% |
| CanBas Co., Ltd. | 2.43 Billion JPY | -185.514% |
| D. Western Therapeutics Institute, Inc. | 2.37 Billion JPY | -192.67% |
| RaQualia Pharma Inc. | 6.93 Billion JPY | -0.229% |
| Chiome Bioscience Inc. | 1.75 Billion JPY | -296.592% |
| Kidswell Bio Corporation | 5.08 Billion JPY | -36.586% |
| PeptiDream Inc. | 67.12 Billion JPY | 89.652% |
| Oncolys BioPharma Inc. | 2.04 Billion JPY | -240.397% |
| Ribomic Inc. | 3.54 Billion JPY | -95.817% |
| SanBio Company Limited | 5.04 Billion JPY | -37.621% |
| Healios K.K. | 15.15 Billion JPY | 54.166% |
| BrightPath Biotherapeutics Co., Ltd. | 1.23 Billion JPY | -464.608% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 3.01 Billion JPY | -130.309% |
| Delta-Fly Pharma, Inc. | 1.47 Billion JPY | -371.194% |
| StemRIM | 9.08 Billion JPY | 23.501% |
| CellSource Co., Ltd. | 6.87 Billion JPY | -0.965% |
| FunPep Company Limited | 2.49 Billion JPY | -178.834% |
| Kringle Pharma, Inc. | 2.61 Billion JPY | -165.256% |
| Stella Pharma Corporation | 3.82 Billion JPY | -81.806% |
| TMS Co., Ltd. | 3.55 Billion JPY | -95.404% |
| Noile-Immune Biotech Inc. | 5.77 Billion JPY | -20.197% |
| Cuorips Inc. | 6.18 Billion JPY | -12.311% |
| K Pharma,Inc. | 3.31 Billion JPY | -109.606% |
| Takara Bio Inc. | 123.2 Billion JPY | 94.362% |
| ReproCELL Incorporated | 9.05 Billion JPY | 23.269% |
| PhoenixBio Co., Ltd. | 2.71 Billion JPY | -155.813% |
| StemCell Institute Inc. | 6.54 Billion JPY | -6.16% |
| Japan Tissue Engineering Co., Ltd. | 6.98 Billion JPY | 0.61% |
| CellSeed Inc. | 2.46 Billion JPY | -181.703% |